Evidence map›Paper›PMID 38627431›Full record

ArticleNature communications2024

Author Correction: Comprehensive mutational scanning of EGFR reveals TKI sensitivities of extracellular domain mutants.

Tikvah K Hayes, Elisa Aquilanti, Nicole S Persky, Xiaoping Yang, Erica E Kim, Lisa Brenan, Amy B Goodale, Douglas Alan, Ted Sharpe, Robert E Shue and 17 more

Abstract readPublished Erratum
PubMed Full text at PMC Publisher
In one paragraph

Article in Nature communications, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

27 authors.

Tikvah K HayesDepartment of Medical Oncology, Dana-Farber Cancer Institute & Harvard Medical School, Boston, MA, USA.
Elisa AquilantiDepartment of Medical Oncology, Dana-Farber Cancer Institute & Harvard Medical School, Boston, MA, USA.
Nicole S PerskyCancer Program, The Broad Institute of M.I.T. and Harvard, Cambridge, MA, USA.
Xiaoping YangGenetic Perturbation Platform, The Broad Institute of M.I.T. and Harvard, Cambridge, MA, USA.ORCID http://orcid.org/0000-0002-6811-4915
Erica E KimDepartment of Medical Oncology, Dana-Farber Cancer Institute & Harvard Medical School, Boston, MA, USA.
Lisa BrenanCancer Program, The Broad Institute of M.I.T. and Harvard, Cambridge, MA, USA.
Amy B GoodaleGenetic Perturbation Platform, The Broad Institute of M.I.T. and Harvard, Cambridge, MA, USA.
Douglas AlanGenetic Perturbation Platform, The Broad Institute of M.I.T. and Harvard, Cambridge, MA, USA.
Ted SharpeData Science Platform, The Broad Institute of M.I.T. and Harvard Cambridge, Cambridge, MA, USA.
Robert E ShueDepartment of Medical Oncology, Dana-Farber Cancer Institute & Harvard Medical School, Boston, MA, USA.
Lindsay WestlakeCancer Program, The Broad Institute of M.I.T. and Harvard, Cambridge, MA, USA.
Lior GolombDepartment of Medical Oncology, Dana-Farber Cancer Institute & Harvard Medical School, Boston, MA, USA.
Brianna R SilvermanDepartment of Medical Oncology, Dana-Farber Cancer Institute & Harvard Medical School, Boston, MA, USA.
Myshal D MorrisSummer Honors Undergraduate Research Program, Harvard Medical School, Boston, MA, USA.
Ty Running FisherSummer Honors Undergraduate Research Program, Harvard Medical School, Boston, MA, USA.
Eden BeyeneSummer Honors Undergraduate Research Program, Harvard Medical School, Boston, MA, USA.
Yvonne Y LiDepartment of Medical Oncology, Dana-Farber Cancer Institute & Harvard Medical School, Boston, MA, USA.ORCID http://orcid.org/0000-0002-1741-1995
Andrew D CherniackDepartment of Medical Oncology, Dana-Farber Cancer Institute & Harvard Medical School, Boston, MA, USA.ORCID http://orcid.org/0000-0003-0470-0111
Federica PiccioniGenetic Perturbation Platform, The Broad Institute of M.I.T. and Harvard, Cambridge, MA, USA.ORCID http://orcid.org/0000-0003-1210-3210
J Kevin HicksDepartment of Pathology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA.
Andrew S ChiCenter for Neuro-Oncology, Division of Neuro-Oncology, Massachusetts General Hospital, Boston, MA, USA.
Daniel P CahillCenter for Neuro-Oncology, Division of Neuro-Oncology, Massachusetts General Hospital, Boston, MA, USA.
Jorg DietrichDepartment of Neurology, Division of Neuro-Oncology, Massachusetts General Hospital, Boston, MA, USA.
Tracy T BatchelorDepartment of Neurology, Brigham and Women's Hospital & Harvard Medical School, Boston, MA, USA.
David E RootGenetic Perturbation Platform, The Broad Institute of M.I.T. and Harvard, Cambridge, MA, USA.ORCID http://orcid.org/0000-0001-5122-861X
Cory M JohannessenCancer Program, The Broad Institute of M.I.T. and Harvard, Cambridge, MA, USA.ORCID http://orcid.org/0000-0002-2618-1036
Matthew MeyersonDepartment of Medical Oncology, Dana-Farber Cancer Institute & Harvard Medical School, Boston, MA, USA. matthew_meyerson@dfci.harvard.edu.ORCID http://orcid.org/0000-0002-9133-8108

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID38627431
PMCPMC11021560

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.